Evaluating the prescribing and monitoring of medications associated with QTc-prolongation in the ambulatory care setting.

Despite national recommendations, medication monitoring and risk mitigation is infrequent when prescribing QTc-prolonging medications in the ambulatory care setting. These findings call for additional research to better understand this gap, including reasons for the gap and consequences on patient outcomes.